SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form 424B4 - Prospectus [Rule 424(b)(4)]:
SEC Accession No. 0001387131-19-005112
Filing Date
2019-07-16
Accepted
2019-07-16 17:03:26
Documents
3

Document Format Files

Seq Description Document Type Size
1 PROSPECTUS tnxp-424b4_071619.htm 424B4 251112
2 GRAPHIC tnxp001.jpg GRAPHIC 12226
3 GRAPHIC tnxp002.jpg GRAPHIC 17998
  Complete submission text file 0001387131-19-005112.txt   294065
Mailing Address 509 MADISON AVE. - SUITE 306 NEW YORK NY 10022
Business Address 509 MADISON AVE. - SUITE 306 NEW YORK NY 10022 1-800-849-7894
Tonix Pharmaceuticals Holding Corp. (Filer) CIK: 0001430306 (see all company filings)

IRS No.: 261434750 | State of Incorp.: NV | Fiscal Year End: 1231
Type: 424B4 | Act: 33 | File No.: 333-232195 | Film No.: 19957636
SIC: 2834 Pharmaceutical Preparations